The use of ablative radiation therapy (A-RT) led to promising overall survival and effective local tumor control in patients ...

PLYMOUTH MEETING, PA — Research published in the April 2025 issue of JNCCN–Journal of the National Comprehensive Cancer ...

Cipla has secured USFDA approval to market a generic version of Abraxane, paclitaxel protein-bound particles for injectable ...

Cipla's Protein-bound Paclitaxel is an AB-rated generic therapeutic equivalent version of Bristol Myers Squibb's Abraxane for Injectable Suspension 100 mg/vial. Protein-bound Paclitaxel is indicated ...